Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
Venture Capital
Biotech
Zenas bags $200M series C to reach a handful of key mAB readouts
Zenas' $200 million series C is the company's second consecutive nine-digit financing.
Max Bayer
May 7, 2024 7:00am
Sofinnova opens biotech creation ‘toolbox’ for Europe strategy
Dec 13, 2023 9:20am
Fosun, Treehill join forces to invest in drugs angling for US
Nov 20, 2023 6:30am
Blue Owl Capital builds bigger nest with Cowen acquisition
Oct 30, 2023 3:04pm
Women left out of VC club fight for their identity
Jun 7, 2023 7:00am
Apax takes stake in CRO Porsolt, to grow staff 40% in 4 years
Feb 23, 2023 7:30am